CRH plc · CRH · FY2024 Q4 · Calendar Q1 2025
CRH pairs margin expansion with infrastructure demand and active M&A
The supplied analysis supports a constructive but conditional view: infrastructure demand, pricing, operating improvements and acquisitions can support continued growth, but the thesis depends on successful integration, resilient volumes and sustained margin improvement.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about CRH FY2024 Q4
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, the supplied current analysis emphasizes completed acquisition activity, additional aggregate reserves, continued margin expansion, higher growth investment and maintained guidance. It also keeps infrastructure funding and pricing at the center of the outlook while highlighting integration, inflation and residential-demand risks.
Guidance delta
Guidance sentiment was maintained in the supplied analysis, with the outlook centered on continued growth, pricing, operating efficiencies and active capital allocation.
Key takeaways
- Management’s supplied analysis describes 2024 revenue growth, adjusted EBITDA growth and an eleventh consecutive year of margin improvement.
- Infrastructure funding, pricing, operating efficiencies and acquisitions were identified as the main growth drivers.
- The supplied analysis describes a large acquisition program, added aggregate reserves and continued investment in capacity, automation and sustainability.
- The central test is whether pricing and infrastructure activity can offset weather, inflation, currency and residential-demand risks.
Management priorities
- Continue active M&A in high-growth markets and integrate recent acquisitions.
- Invest in automation, capacity expansion, sustainability and water-infrastructure manufacturing.
- Maintain pricing, operating efficiency and capital-allocation initiatives while pursuing infrastructure opportunities.
Follow CRH with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 25, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Overweight | Overweight | Maintain | Oct 19, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 9, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 5, 2026 |
| Truist Securities | Buy | Buy | Maintain | Oct 5, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 2, 2026 |
| UBS | Buy | Buy | Maintain | Sep 22, 2026 |
| Stephens & Co. | Overweight | Overweight | Maintain | Jul 31, 2026 |
| Jefferies | Buy | Buy | Maintain | Jun 26, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Mar 3, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Mar 2, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | Nov 12, 2025 |
| Bernstein | Outperform | Outperform | Maintain | Sep 11, 2025 |
| Stifel | Hold | Buy | Downgrade | Apr 15, 2024 |
| Redburn Partners | Buy | Neutral | Upgrade | Jan 3, 2023 |
| Berenberg | Hold | Hold | Maintain | Jan 14, 2021 |
| Canaccord Genuity | Buy | Hold | Upgrade | Nov 2, 2016 |
| Societe Generale | Hold | Buy | Downgrade | Aug 26, 2016 |
| Bank of America | Neutral | Underperform | Upgrade | Apr 25, 2016 |
| B of A Securities | Neutral | Underperform | Upgrade | Apr 24, 2016 |
| HSBC | Buy | Hold | Upgrade | Jan 27, 2016 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Jan 15, 2016 |
Named analyst price targets
Upside is calculated against the persisted current price $84.89. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Analyst unavailable | $110 | $83.63 | +29.6% | Oct 19, 2026 |
| Deutsche Bank | Analyst unavailable | $118 | $81.56 | +39.0% | Oct 9, 2026 |
| RBC Capital | Analyst unavailable | $135 | $82 | +59.0% | Oct 9, 2026 |
| Truist Financial | Analyst unavailable | $105 | $81.94 | +23.7% | Oct 5, 2026 |
| Wells Fargo | Analyst unavailable | $106 | $81.94 | +24.9% | Oct 5, 2026 |
| UBS | Analyst unavailable | $135 | $88 | +59.0% | Sep 22, 2026 |
| Wells Fargo | Analyst unavailable | $107 | $90.61 | +26.0% | Sep 9, 2026 |
| Berenberg Bank | Harry Goad | $140 | $92.24 | +64.9% | Sep 8, 2026 |
| D.A. Davidson | Garik Shmois | $137 | $95.79 | +61.4% | Aug 24, 2026 |
| Stephens | Analyst unavailable | $125 | $96 | +47.2% | Jul 31, 2026 |
| Wells Fargo | Analyst unavailable | $132 | $106.21 | +55.5% | Jul 8, 2026 |
| Jefferies | Analyst unavailable | $165.6 | $113.05 | +95.1% | Jun 26, 2026 |
| Morgan Stanley | Angel Castillo | $139 | $116.19 | +63.7% | Apr 15, 2026 |
| D.A. Davidson | Analyst unavailable | $120 | $125.17 | +41.4% | Feb 20, 2026 |
| Wells Fargo | Analyst unavailable | $133 | $122.46 | +56.7% | Jan 29, 2026 |
| Wells Fargo | Analyst unavailable | $138 | $131.38 | +62.6% | Jan 13, 2026 |
| UBS | Analyst unavailable | $147 | $122.76 | +73.2% | Jan 8, 2026 |
| Morgan Stanley | Angel Castillo | $140 | $123.68 | +64.9% | Dec 10, 2025 |
| Deutsche Bank | Analyst unavailable | $139 | $119.49 | +63.7% | Dec 8, 2025 |
| Barclays | Adam Seiden | $131 | $117.46 | +54.3% | Oct 20, 2025 |
| UBS | Julian Radlinger | $138 | $117.54 | +62.6% | Oct 14, 2025 |
| Morgan Stanley | Analyst unavailable | $134 | $117.85 | +57.9% | Oct 9, 2025 |
| Wells Fargo | Analyst unavailable | $135 | $116.34 | +59.0% | Oct 7, 2025 |
| UBS | Analyst unavailable | $140 | $121.1 | +64.9% | Oct 2, 2025 |
| UBS | Analyst unavailable | $152 | $119.9 | +79.1% | Oct 1, 2025 |
| RBC Capital | Anthony Codling | $108 | $85.78 | +27.2% | Apr 14, 2025 |
| Berenberg Bank | Analyst unavailable | $120 | $102.52 | +41.4% | Feb 28, 2025 |
| Truist Financial | Keith Hughes | $110 | $82.79 | +29.6% | Aug 9, 2024 |
| Morgan Stanley | Cedar Ekblom | $88 | $74.23 | +3.7% | Jul 9, 2024 |
| Truist Financial | Keith Hughes | $100 | $83.44 | +17.8% | May 13, 2024 |
| Truist Financial | Keith Hughes | $81 | $67.5 | -4.6% | Dec 14, 2023 |
Track every rating change on CRH the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCRH plc, together with its subsidiaries, provides building materials solutions in Ireland, the United States, the United Kingdom, rest of Europe, and internationally. It operates through three segments: Americas Materials Solutions, Americas Building Solutions, and International Solutions. The company offers building materials for the construction and maintenance of public infrastructure, and commercial and residential buildings, as well as construction and renovation of transportation infrastructure, critical utility networks, commercial and residential buildings, and outdoor living spaces; paving and construction services; and produces and sells aggregates, cementitious materials, ready mixed concrete and mortars, and asphalt.…
Historical context
All CRH earningsBasic Materials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CRS Carpenter Technology Corporation | FY2027 Q1 · Calendar Q4 2026 | +6.9% | -20.6% | CRS: Aerospace Bookings Accelerate as Guidance Holds |
| DOW Dow Inc. | FY2026 Q3 · Calendar Q4 2026 | +11.3% | +4.7% | Dow’s Q3 growth and self-help gains support a steady Q4 outlook |
| NEM Newmont Corporation | FY2026 Q3 · Calendar Q4 2026 | +12.2% | -2.6% | Newmont Holds 2026 Guidance as Projects Set Up 2027 Growth |
| SCCO Southern Copper Corporation | FY2026 Q3 · Calendar Q4 2026 | +6.4% | -2.1% | Southern Copper: Record Q3 results, projects advance amid execution risks |
Latest beats and misses
Who reports nextBeat on EPS
- FCNCAFY2026 Q3 · October 23, 2026+19.9% EPS+8.2% move
- FCNCNFY2026 Q3 · October 23, 2026+19.9% EPS+0.2% move
- FCNCOFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- FCNCPFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- RDYFY2027 Q2 · October 23, 2026+24.0% EPS-0.2% move
- SLBFY2026 Q3 · October 23, 2026+3.7% EPS+7.1% move
Missed on EPS
- INFYFY2027 Q2 · October 23, 2026-4.8% EPS-6.6% move
- BBDFY2026 Q3 · October 22, 2026-7.7% EPS+3.0% move
- SNAFY2026 Q3 · October 22, 2026-5.9% EPS-3.4% move
- SPOTFY2026 Q3 · October 22, 2026-11.6% EPS+11.1% move
- VRSNFY2026 Q3 · October 22, 2026-2.0% EPS-0.9% move
- HBANMFY2026 Q3 · October 22, 2026-5.3% EPS+0.5% move
Get the CRH recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-02-20T12:30:13.355938+00:00
- Polygon adjusted daily market bars · 2026-10-25T09:50:42.992882+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-25T09:50:42.990015+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-25. For educational purposes only; not investment advice.